Sanofi SA - Ebit

Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.

The item "Ebit" stands at 9.47 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025.

Sanofi SA's third quarter result of 3.74 Billion EUR for the item "Ebit" represents an increase of 93.32 percent compared to it's second quarter result.

Also, Sanofi SA's third quarter result of 3.74 Billion EUR for the item "Ebit" represents a decrease of -8.43 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 9.47 Billion EUR for the item "Ebit" represents a decrease of -3.51 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 27.36 percent compared to the value the year prior.
The 1 year change in percent is 27.36.
The 3 year change in percent is -8.12.
The 5 year change in percent is 36.28.
The 10 year change in percent is 24.64.

The Serie's long term average value is 7.57 Billion Euros. It's latest available value, on 09/30/2025, is 25.04 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is +69.54%.
The Serie's change in percent from it's maximum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is -13.72%.